Moneta Group Investment Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $555K | Buy |
1,246
+74
| +6% | +$33K | 0.01% | 415 |
|
|
2025
Q1 | $568K | Buy |
1,172
+112
| +11% | +$54.3K | 0.01% | 390 |
|
|
2024
Q4 | $427K | Sell |
1,060
-246
| -19% | -$99.1K | 0.01% | 437 |
|
|
2024
Q3 | $607K | Buy |
1,306
+49
| +4% | +$22.8K | 0.01% | 368 |
|
|
2024
Q2 | $589K | Sell |
1,257
-79
| -6% | -$37K | 0.01% | 351 |
|
|
2024
Q1 | $558K | Buy |
1,336
+387
| +41% | +$162K | 0.01% | 358 |
|
|
2023
Q4 | $386K | Buy |
949
+64
| +7% | +$26K | 0.01% | 382 |
|
|
2023
Q3 | $308K | Sell |
885
-106
| -11% | -$36.9K | 0.01% | 400 |
|
|
2023
Q2 | $349K | Buy |
991
+168
| +20% | +$59.1K | 0.01% | 401 |
|
|
2023
Q1 | $259K | Buy |
+823
| New | +$259K | 0.01% | 450 |
|
|
2018
Q1 | – | Sell |
-3
| Closed | – | – | 720 |
|
|
2017
Q4 | $0 | Buy |
+3
| New | – | ﹤0.01% | 549 |
|